![Martyn Greenacre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martyn Greenacre
Chairman at
CURIS, INC.
Net worth: 740 $ as of 2026-05-30
Profile
Martyn D.
Greenacre is currently Chairman at Curis, Inc. since 2017, Chairman at Life Mist Technologies, Inc. since 2002, and Director at Formula Pharmaceuticals, Inc. Former roles include President & Chief Executive Officer at Zynaxis, Inc. in 1997, Chief Executive Officer & Director at Delsys Pharmaceutical Corp.
in 2001, Chairman at Life Mist LLC from 2001 to 2016, Chairman at Beijing Med-Pharm Corp.
in 2008, Director & Chairman-European Operations at Smithkline Beecham Pharmaceuticals (India) Ltd. from 1989 to 1992, Chairman at BMP Sunstone Corp.
from 2004 to 2011, Director at Cephalon LLC from 1992 to 2011, Director at Creative Biomolecules, Inc. from 1993 to 2000, Director at Orchestra Therapeutics, Inc. in 2008, Director at Acusphere, Inc. from 2001 to 2013, Director at NeoStem, Inc., Director at Caladrius Biosciences, Inc. in 2011, Member-Executive Committee at Applera Corp., and Senior Advisor at Arsenal Capital Management LP.
Education includes an MBA from Harvard Business School and undergraduate studies at Harvard College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-22 | 1,305 ( 0% ) | 740 $ | 2026-05-30 |
Martyn Greenacre active positions
| Companies | Position | Start |
|---|---|---|
| CURIS, INC. | Chairman | 2017-05-15 |
Formula Pharmaceuticals, Inc.
 Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops chimeric antigen receptor immunotherapy platform | Director/Board Member | - |
Life Mist Technologies, Inc. | Chairman | 2001-12-31 |
Former positions of Martyn Greenacre
| Companies | Position | End |
|---|---|---|
Life Mist LLC | Chairman | 2016-11-30 |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Private Equity Investor | 2011-03-30 |
BMP Sunstone Corp.
 BMP Sunstone Corp. Medical/Nursing ServicesHealth Services Provides pre-market analysis, clinical trials and product registration | Chairman | 2011-01-31 |
Beijing Med-Pharm Corp.
 Beijing Med-Pharm Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals | Chairman | 2008-02-18 |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Operates as a development stage company | Director/Board Member | 2007-12-31 |
Training of Martyn Greenacre
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Develops products for human tissue regeneration and organs based on morphogenic proteins | Health Technology |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Zynaxis, Inc.
 Zynaxis, Inc. Miscellaneous Commercial ServicesCommercial Services Develops drug delivery systems | Commercial Services |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Manufactures medical instruments | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Acusphere, Inc.
 Acusphere, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs | Health Technology |
Life Mist LLC | |
Beijing Med-Pharm Corp.
Beijing Med-Pharm Corp. Medical DistributorsDistribution Services Distributes pharmaceuticals | Distribution Services |
Arsenal Capital Management LP
Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital invests in middle market companies located in the United States. The firm focuses on healthcare and industrial sectors. It participates in buyouts, add-on acquisitions and growth stage capital transactions. | Finance |
Delsys Pharmaceutical Corp.
 Delsys Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
NeoStem, Inc. /Old/
 NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | Transportation |
Smithkline Beecham Pharmaceuticals (India) Ltd.
 Smithkline Beecham Pharmaceuticals (India) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
Life Mist Technologies, Inc. | |
BMP Sunstone Corp.
BMP Sunstone Corp. Medical/Nursing ServicesHealth Services Provides pre-market analysis, clinical trials and product registration | Health Services |
Formula Pharmaceuticals, Inc.
Formula Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops chimeric antigen receptor immunotherapy platform | Technology Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Martyn Greenacre
